Crispr stock price zacks
WebApr 14, 2024 · Another stock in the Medical sector, CRISPR Therapeutics AG (CRSP Quick Quote CRSP - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 24.4%. The ... WebApr 15, 2024 · Zacks Apr. 14, 2024, 06:00 PM CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $50.31, moving -0.49% from the previous trading session. This change lagged the S&P 500's daily...
Crispr stock price zacks
Did you know?
Web1 day ago · The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> CRISPR Therapeutics AG is a member of the Zacks Medical ... WebCrispr Therapeutics stock price target cut to $52 from $64 at Stifel Nicolaus May. 10, 2024 at 8:12 a.m. ET by Tomi Kilgore Biotech and Pharma Patent Ruling Is a Setback for …
WebMar 21, 2024 · You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. JSPR’s loss per share estimates have narrowed from $1.42 to 61 cents for 2024 … Web2 days ago · CRISPR Therapeutics AG (CRSP) closed the last trading session at $45.41, gaining 0.6% over the past four weeks, but there could be plenty of upside left in the …
WebApr 14, 2024 · Zacks Apr. 14, 2024, 03:13 AM CRISPR Therapeutics AG CRSP shares soared 16.3% in the last trading session to close at $50.56. The move was backed by … WebMar 28, 2024 · In the past 90 days, the Zacks Consensus Estimate for Aptinyx’s 2024 loss per share has narrowed from 77 cents to 56 cents. In the year so far, the shares of Aptinyx have declined 94.8%. APTX...
WebApr 12, 2024 · While Certara and EQRx sport a Zacks Rank #1 (Strong Buy), CRISPR Therapeutics carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here .
Web2 days ago · CRISPR Therapeutics - CRSP - Stock Price Today - Zacks CRISPR Therapeutics (CRSP) (Delayed Data from NSDQ) $44.80 USD +1.09 (2.49%) Updated … Learn more about Crispr Therapeutics's (CRSP) upcoming earnings … Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, … Eps Diluted (Quarterly) is a widely used stock evaluation measure. Find the … As you know, the Zacks Rank is one of the most successful stock rating systems … The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries … Crispr Therapeutics price target lowered to $55 from $63 at Citi ... Zacks Rank stock … CRSP: CRISPR Therapeutics - Insider Transactions Get the latest Insider … The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries … The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) … CRSP: CRISPR Therapeutics broker recommendation chart. Get the latest … dingle community primary school term datesWebCRSP - CRISPR Therapeutics AG Stock Price and Quote TIP: Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. × publish chart save to portfolio create alert compare perf. Candle - advanced Intraday Daily Weekly Draw Fullscreen Settings CRSP - Stock Price Chart CRSP [NASD] CRISPR Therapeutics AG fort myers internal medicine haddadWeb2 days ago · The mean of analysts' price targets for CRISPR Therapeutics AG (CRSP) points to a 105.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong ... fort myers internal medicineWebApr 14, 2024 · Zacks Rank & Stocks to Consider. Currently, Regulus has a Zacks Rank #3 (Hold). Some better-ranked stocks for investors interested in the same sector are CRISPR Therapeutics (CRSP Quick Quote CRSP ... fort myers internal medicine llcWebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … dingle community primary school websiteWebMar 21, 2024 · You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. JSPR’s loss per share estimates have narrowed from $1.42 to 61 cents for 2024 and from $1.6 to 59 cents for 2024,... dingle community primaryWebWall Street Analysts Think CRISPR Therapeutics AG (CRSP) Could Surge 105.26%: Read This Before Placing a Bet Apr 12 / Zacks.com - Paid Partner Content 2 Nasdaq Growth … fort myers infiniti owner